Psycheceutical Bioscience, Inc

About Psycheceutical Bioscience, Inc

Psycheceutical, Inc. is a biotech company focused on developing cutting-edge technologies to enhance the safety and efficacy of psychedelic pharmaceutical medicines for mental health treatment, particularly for neuropsychiatric and pain conditions. Their mission is to improve patient outcomes and quality of life through innovative delivery systems.

Products & Services

NeuroDirect™ Non-Systemic Delivery Technology:A patented topical application technology designed to deliver neuro-active compounds directly into nerve tissue at the back of the neck, enabling immediate and sustained delivery with safe dosage control and minimal side effects by avoiding the GI tract.

NeuroDirect™ Ketamine for PTSD:A topical ketamine formulation under clinical trials (Phase I completed first cohort dosing) aimed at treating PTSD with reduced risk of hallucinations and other side effects.

Specialties

Psychedelic Therapeutics Neuropsychiatric Treatment Pain Management Non-Systemic Drug Delivery Topical Ketamine Applications

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Crowdfunding T: - FT: Crowdfunding	A: 250 MR: - FA: $250 USD FAN: 250	D: 2023-11-01 FD: 2023-11-01	1 investors

Crowdfunding Latest

2023-11-01

$250

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

N

Neilank K. Jha

Chief Executive Officer & Executive Chairman

C

Chad Harman

President

K

Kevin Harrington

Strategic Advisor

M

Michael Hlavsa

Chief Financial Officer

J

Julian E. Bailes

Chief Medical Officer

T

Thomas Cabell

Medical Advisor

View 9 more team members with Pro

Unlock Full Team Directory

Recent News